HEADER HYDROLASE/HYDROLASE INHIBITOR 23-MAY-11 3S5Y TITLE PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-GALACTOSIDASE A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 32-429; COMPND 5 SYNONYM: ALPHA-D-GALACTOSIDASE A, ALPHA-D-GALACTOSIDE COMPND 6 GALACTOHYDROLASE, MELIBIASE; COMPND 7 EC: 3.2.1.22; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GLA; SOURCE 6 EXPRESSION_SYSTEM: NICOTIANA BENTHAMIANA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4100 KEYWDS GLYCOPROTEIN, CARBOHYDRATE-BINDING PROTEIN, GLYCOSIDASE, LYSOSOMAL KEYWDS 2 ENZYME, (BETA/ALPHA)8 BARREL, PHARMACOLOGICAL CHAPERONE, HYDROLASE- KEYWDS 3 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.I.GUCE,N.E.CLARK,S.C.GARMAN REVDAT 5 30-OCT-24 3S5Y 1 REMARK REVDAT 4 13-SEP-23 3S5Y 1 HETSYN REVDAT 3 29-JUL-20 3S5Y 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 04-APR-12 3S5Y 1 HEADER REVDAT 1 04-JAN-12 3S5Y 0 JRNL AUTH A.I.GUCE,N.E.CLARK,J.J.ROGICH,S.C.GARMAN JRNL TITL THE MOLECULAR BASIS OF PHARMACOLOGICAL CHAPERONING IN HUMAN JRNL TITL 2 ALPHA-GALACTOSIDASE JRNL REF CHEM.BIOL. V. 18 1521 2011 JRNL REFN ISSN 1074-5521 JRNL PMID 22195554 JRNL DOI 10.1016/J.CHEMBIOL.2011.10.012 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 66564 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3360 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.11 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4269 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.57 REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE SET COUNT : 227 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6253 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 403 REMARK 3 SOLVENT ATOMS : 440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.70000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : 0.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.192 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.169 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.506 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6903 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4706 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9394 ; 1.126 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11345 ; 0.818 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 791 ; 5.650 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 321 ;35.459 ;24.206 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1062 ;13.369 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;14.117 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1029 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7408 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1384 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3913 ; 2.161 ; 6.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1592 ; 0.825 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6276 ; 3.486 ; 8.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2990 ; 5.370 ;12.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3114 ; 8.098 ;18.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 32 A 328 4 REMARK 3 1 B 32 B 328 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 4090 ; 0.220 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 4090 ; 2.280 ;20.000 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 329 A 420 4 REMARK 3 1 B 329 B 420 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 A (A): 1242 ; 0.310 ; 0.500 REMARK 3 MEDIUM THERMAL 2 A (A**2): 1242 ; 3.180 ;20.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 32 A 328 REMARK 3 ORIGIN FOR THE GROUP (A): 42.1131 14.2799 22.0699 REMARK 3 T TENSOR REMARK 3 T11: 0.0997 T22: 0.1358 REMARK 3 T33: 0.1668 T12: 0.0134 REMARK 3 T13: -0.0214 T23: -0.0159 REMARK 3 L TENSOR REMARK 3 L11: 0.1166 L22: 1.7571 REMARK 3 L33: 0.4102 L12: 0.2650 REMARK 3 L13: -0.0744 L23: -0.1325 REMARK 3 S TENSOR REMARK 3 S11: 0.0272 S12: 0.0174 S13: 0.0060 REMARK 3 S21: 0.1164 S22: -0.0070 S23: -0.0617 REMARK 3 S31: 0.0828 S32: 0.0220 S33: -0.0202 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 329 A 421 REMARK 3 ORIGIN FOR THE GROUP (A): 55.0878 40.7721 12.9601 REMARK 3 T TENSOR REMARK 3 T11: 0.0114 T22: 0.2100 REMARK 3 T33: 0.2988 T12: -0.0138 REMARK 3 T13: 0.0158 T23: -0.0168 REMARK 3 L TENSOR REMARK 3 L11: 1.0132 L22: 1.3654 REMARK 3 L33: 0.3680 L12: -0.1521 REMARK 3 L13: -0.3569 L23: -0.2572 REMARK 3 S TENSOR REMARK 3 S11: 0.0249 S12: 0.0505 S13: 0.1322 REMARK 3 S21: 0.0631 S22: 0.0258 S23: -0.2544 REMARK 3 S31: -0.0174 S32: 0.0828 S33: -0.0507 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 32 B 328 REMARK 3 ORIGIN FOR THE GROUP (A): 26.5292 59.4900 26.9396 REMARK 3 T TENSOR REMARK 3 T11: 0.1120 T22: 0.1619 REMARK 3 T33: 0.1099 T12: 0.0229 REMARK 3 T13: 0.0212 T23: 0.0041 REMARK 3 L TENSOR REMARK 3 L11: 0.4183 L22: 0.8933 REMARK 3 L33: 0.5239 L12: 0.0882 REMARK 3 L13: -0.0060 L23: -0.0263 REMARK 3 S TENSOR REMARK 3 S11: -0.0011 S12: -0.0020 S13: -0.0369 REMARK 3 S21: 0.0093 S22: 0.0067 S23: -0.0160 REMARK 3 S31: -0.1266 S32: -0.0562 S33: -0.0056 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 329 B 422 REMARK 3 ORIGIN FOR THE GROUP (A): 10.4418 32.9696 27.7960 REMARK 3 T TENSOR REMARK 3 T11: 0.0446 T22: 0.1812 REMARK 3 T33: 0.2850 T12: -0.0373 REMARK 3 T13: 0.0564 T23: -0.0029 REMARK 3 L TENSOR REMARK 3 L11: 2.1475 L22: 1.6069 REMARK 3 L33: 0.7297 L12: -0.9312 REMARK 3 L13: -0.1140 L23: 0.3143 REMARK 3 S TENSOR REMARK 3 S11: -0.0987 S12: -0.0167 S13: -0.3399 REMARK 3 S21: 0.0724 S22: -0.0517 S23: 0.3400 REMARK 3 S31: 0.1150 S32: -0.1307 S33: 0.1504 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 3S5Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065802. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(111) CHANNEL CUT REMARK 200 OPTICS : TOROIDAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66778 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.81600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 3HG5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8-15% PEG 8000, 0.1 M SODIUM REMARK 280 CACODYLATE, 0.02 M MAGNESIUM CHLORIDE, PH 5.1, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 68.40650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 91.31750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 68.40650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 91.31750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 98.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 422 REMARK 465 MET A 423 REMARK 465 SER A 424 REMARK 465 LEU A 425 REMARK 465 LYS A 426 REMARK 465 ASP A 427 REMARK 465 LEU A 428 REMARK 465 LEU A 429 REMARK 465 MET B 423 REMARK 465 SER B 424 REMARK 465 LEU B 425 REMARK 465 LYS B 426 REMARK 465 ASP B 427 REMARK 465 LEU B 428 REMARK 465 LEU B 429 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 51 -134.15 55.21 REMARK 500 CYS A 52 51.22 -113.38 REMARK 500 ASP A 92 -150.45 -101.62 REMARK 500 CYS A 94 19.99 83.56 REMARK 500 ASP A 266 -176.02 90.63 REMARK 500 ASN A 272 -131.72 -98.84 REMARK 500 MET B 51 -137.27 55.91 REMARK 500 CYS B 52 52.15 -112.44 REMARK 500 ASP B 92 -152.74 -102.03 REMARK 500 CYS B 94 17.18 81.14 REMARK 500 ASP B 266 -176.52 89.65 REMARK 500 ASN B 272 -127.23 -96.94 REMARK 500 GLU B 358 40.13 -102.67 REMARK 500 MET B 421 47.64 -100.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 2PE A 813 REMARK 610 2PE B 810 REMARK 610 2PE B 812 REMARK 610 2PE B 815 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3S5Z RELATED DB: PDB REMARK 900 RELATED ID: 3HG2 RELATED DB: PDB REMARK 900 RELATED ID: 3HG3 RELATED DB: PDB REMARK 900 RELATED ID: 3HG4 RELATED DB: PDB REMARK 900 RELATED ID: 3HG5 RELATED DB: PDB REMARK 900 RELATED ID: 1R46 RELATED DB: PDB REMARK 900 RELATED ID: 1R47 RELATED DB: PDB DBREF 3S5Y A 32 429 UNP P06280 AGAL_HUMAN 32 429 DBREF 3S5Y B 32 429 UNP P06280 AGAL_HUMAN 32 429 SEQRES 1 A 398 LEU ASP ASN GLY LEU ALA ARG THR PRO THR MET GLY TRP SEQRES 2 A 398 LEU HIS TRP GLU ARG PHE MET CYS ASN LEU ASP CYS GLN SEQRES 3 A 398 GLU GLU PRO ASP SER CYS ILE SER GLU LYS LEU PHE MET SEQRES 4 A 398 GLU MET ALA GLU LEU MET VAL SER GLU GLY TRP LYS ASP SEQRES 5 A 398 ALA GLY TYR GLU TYR LEU CYS ILE ASP ASP CYS TRP MET SEQRES 6 A 398 ALA PRO GLN ARG ASP SER GLU GLY ARG LEU GLN ALA ASP SEQRES 7 A 398 PRO GLN ARG PHE PRO HIS GLY ILE ARG GLN LEU ALA ASN SEQRES 8 A 398 TYR VAL HIS SER LYS GLY LEU LYS LEU GLY ILE TYR ALA SEQRES 9 A 398 ASP VAL GLY ASN LYS THR CYS ALA GLY PHE PRO GLY SER SEQRES 10 A 398 PHE GLY TYR TYR ASP ILE ASP ALA GLN THR PHE ALA ASP SEQRES 11 A 398 TRP GLY VAL ASP LEU LEU LYS PHE ASP GLY CYS TYR CYS SEQRES 12 A 398 ASP SER LEU GLU ASN LEU ALA ASP GLY TYR LYS HIS MET SEQRES 13 A 398 SER LEU ALA LEU ASN ARG THR GLY ARG SER ILE VAL TYR SEQRES 14 A 398 SER CYS GLU TRP PRO LEU TYR MET TRP PRO PHE GLN LYS SEQRES 15 A 398 PRO ASN TYR THR GLU ILE ARG GLN TYR CYS ASN HIS TRP SEQRES 16 A 398 ARG ASN PHE ALA ASP ILE ASP ASP SER TRP LYS SER ILE SEQRES 17 A 398 LYS SER ILE LEU ASP TRP THR SER PHE ASN GLN GLU ARG SEQRES 18 A 398 ILE VAL ASP VAL ALA GLY PRO GLY GLY TRP ASN ASP PRO SEQRES 19 A 398 ASP MET LEU VAL ILE GLY ASN PHE GLY LEU SER TRP ASN SEQRES 20 A 398 GLN GLN VAL THR GLN MET ALA LEU TRP ALA ILE MET ALA SEQRES 21 A 398 ALA PRO LEU PHE MET SER ASN ASP LEU ARG HIS ILE SER SEQRES 22 A 398 PRO GLN ALA LYS ALA LEU LEU GLN ASP LYS ASP VAL ILE SEQRES 23 A 398 ALA ILE ASN GLN ASP PRO LEU GLY LYS GLN GLY TYR GLN SEQRES 24 A 398 LEU ARG GLN GLY ASP ASN PHE GLU VAL TRP GLU ARG PRO SEQRES 25 A 398 LEU SER GLY LEU ALA TRP ALA VAL ALA MET ILE ASN ARG SEQRES 26 A 398 GLN GLU ILE GLY GLY PRO ARG SER TYR THR ILE ALA VAL SEQRES 27 A 398 ALA SER LEU GLY LYS GLY VAL ALA CYS ASN PRO ALA CYS SEQRES 28 A 398 PHE ILE THR GLN LEU LEU PRO VAL LYS ARG LYS LEU GLY SEQRES 29 A 398 PHE TYR GLU TRP THR SER ARG LEU ARG SER HIS ILE ASN SEQRES 30 A 398 PRO THR GLY THR VAL LEU LEU GLN LEU GLU ASN THR MET SEQRES 31 A 398 GLN MET SER LEU LYS ASP LEU LEU SEQRES 1 B 398 LEU ASP ASN GLY LEU ALA ARG THR PRO THR MET GLY TRP SEQRES 2 B 398 LEU HIS TRP GLU ARG PHE MET CYS ASN LEU ASP CYS GLN SEQRES 3 B 398 GLU GLU PRO ASP SER CYS ILE SER GLU LYS LEU PHE MET SEQRES 4 B 398 GLU MET ALA GLU LEU MET VAL SER GLU GLY TRP LYS ASP SEQRES 5 B 398 ALA GLY TYR GLU TYR LEU CYS ILE ASP ASP CYS TRP MET SEQRES 6 B 398 ALA PRO GLN ARG ASP SER GLU GLY ARG LEU GLN ALA ASP SEQRES 7 B 398 PRO GLN ARG PHE PRO HIS GLY ILE ARG GLN LEU ALA ASN SEQRES 8 B 398 TYR VAL HIS SER LYS GLY LEU LYS LEU GLY ILE TYR ALA SEQRES 9 B 398 ASP VAL GLY ASN LYS THR CYS ALA GLY PHE PRO GLY SER SEQRES 10 B 398 PHE GLY TYR TYR ASP ILE ASP ALA GLN THR PHE ALA ASP SEQRES 11 B 398 TRP GLY VAL ASP LEU LEU LYS PHE ASP GLY CYS TYR CYS SEQRES 12 B 398 ASP SER LEU GLU ASN LEU ALA ASP GLY TYR LYS HIS MET SEQRES 13 B 398 SER LEU ALA LEU ASN ARG THR GLY ARG SER ILE VAL TYR SEQRES 14 B 398 SER CYS GLU TRP PRO LEU TYR MET TRP PRO PHE GLN LYS SEQRES 15 B 398 PRO ASN TYR THR GLU ILE ARG GLN TYR CYS ASN HIS TRP SEQRES 16 B 398 ARG ASN PHE ALA ASP ILE ASP ASP SER TRP LYS SER ILE SEQRES 17 B 398 LYS SER ILE LEU ASP TRP THR SER PHE ASN GLN GLU ARG SEQRES 18 B 398 ILE VAL ASP VAL ALA GLY PRO GLY GLY TRP ASN ASP PRO SEQRES 19 B 398 ASP MET LEU VAL ILE GLY ASN PHE GLY LEU SER TRP ASN SEQRES 20 B 398 GLN GLN VAL THR GLN MET ALA LEU TRP ALA ILE MET ALA SEQRES 21 B 398 ALA PRO LEU PHE MET SER ASN ASP LEU ARG HIS ILE SER SEQRES 22 B 398 PRO GLN ALA LYS ALA LEU LEU GLN ASP LYS ASP VAL ILE SEQRES 23 B 398 ALA ILE ASN GLN ASP PRO LEU GLY LYS GLN GLY TYR GLN SEQRES 24 B 398 LEU ARG GLN GLY ASP ASN PHE GLU VAL TRP GLU ARG PRO SEQRES 25 B 398 LEU SER GLY LEU ALA TRP ALA VAL ALA MET ILE ASN ARG SEQRES 26 B 398 GLN GLU ILE GLY GLY PRO ARG SER TYR THR ILE ALA VAL SEQRES 27 B 398 ALA SER LEU GLY LYS GLY VAL ALA CYS ASN PRO ALA CYS SEQRES 28 B 398 PHE ILE THR GLN LEU LEU PRO VAL LYS ARG LYS LEU GLY SEQRES 29 B 398 PHE TYR GLU TRP THR SER ARG LEU ARG SER HIS ILE ASN SEQRES 30 B 398 PRO THR GLY THR VAL LEU LEU GLN LEU GLU ASN THR MET SEQRES 31 B 398 GLN MET SER LEU LYS ASP LEU LEU MODRES 3S5Y ASN A 192 ASN GLYCOSYLATION SITE MODRES 3S5Y ASN A 139 ASN GLYCOSYLATION SITE MODRES 3S5Y ASN B 192 ASN GLYCOSYLATION SITE MODRES 3S5Y ASN B 215 ASN GLYCOSYLATION SITE MODRES 3S5Y ASN B 139 ASN GLYCOSYLATION SITE MODRES 3S5Y ASN A 215 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET XYP C 4 9 HET MAN C 5 11 HET MAN C 6 11 HET FUC C 7 10 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET XYP D 4 9 HET FUC D 5 10 HET NAG E 1 14 HET FUC E 2 10 HET NAG E 3 14 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET XYP F 4 9 HET MAN F 5 11 HET NAG G 1 14 HET NAG G 2 14 HET BMA G 3 11 HET FUC G 4 10 HET DGJ A 801 11 HET 2PE A 813 10 HET NAG B 639 14 HET DGJ B 802 11 HET 2PE B 810 16 HET 2PE B 811 28 HET 2PE B 812 7 HET EDO B 814 4 HET 2PE B 815 10 HET ACY B 842 4 HET ACY B 843 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM XYP BETA-D-XYLOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM DGJ (2R,3S,4R,5S)-2-(HYDROXYMETHYL)PIPERIDINE-3,4,5-TRIOL HETNAM 2PE NONAETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETNAM ACY ACETIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN XYP BETA-D-XYLOSE; D-XYLOSE; XYLOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN DGJ 1-DEOXYGALACTONOJIRIMYCIN HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 11(C8 H15 N O6) FORMUL 3 BMA 4(C6 H12 O6) FORMUL 3 XYP 3(C5 H10 O5) FORMUL 3 MAN 3(C6 H12 O6) FORMUL 3 FUC 4(C6 H12 O5) FORMUL 8 DGJ 2(C6 H13 N O4) FORMUL 9 2PE 5(C18 H38 O10) FORMUL 15 EDO C2 H6 O2 FORMUL 17 ACY 2(C2 H4 O2) FORMUL 19 HOH *440(H2 O) HELIX 1 1 HIS A 46 MET A 51 1 6 HELIX 2 2 SER A 65 GLU A 79 1 15 HELIX 3 3 GLY A 80 GLY A 85 1 6 HELIX 4 4 HIS A 115 LYS A 127 1 13 HELIX 5 5 TYR A 151 GLY A 163 1 13 HELIX 6 6 SER A 176 GLY A 195 1 20 HELIX 7 7 GLU A 203 TRP A 209 1 7 HELIX 8 8 ASN A 215 CYS A 223 1 9 HELIX 9 9 SER A 235 ASN A 249 1 15 HELIX 10 10 ASN A 249 VAL A 254 1 6 HELIX 11 11 SER A 276 MET A 290 1 15 HELIX 12 12 SER A 304 GLN A 312 1 9 HELIX 13 13 ASP A 313 GLN A 321 1 9 HELIX 14 14 ALA A 370 VAL A 376 5 7 HELIX 15 15 HIS B 46 MET B 51 1 6 HELIX 16 16 SER B 65 GLU B 79 1 15 HELIX 17 17 GLY B 80 GLY B 85 1 6 HELIX 18 18 HIS B 115 LYS B 127 1 13 HELIX 19 19 TYR B 151 GLY B 163 1 13 HELIX 20 20 SER B 176 THR B 194 1 19 HELIX 21 21 GLU B 203 TRP B 209 1 7 HELIX 22 22 ASN B 215 CYS B 223 1 9 HELIX 23 23 SER B 235 ASN B 249 1 15 HELIX 24 24 ASN B 249 VAL B 254 1 6 HELIX 25 25 SER B 276 MET B 290 1 15 HELIX 26 26 SER B 304 GLN B 312 1 9 HELIX 27 27 ASP B 313 GLN B 321 1 9 HELIX 28 28 ALA B 370 VAL B 376 5 7 SHEET 1 A 8 TRP A 262 ASP A 264 0 SHEET 2 A 8 HIS A 225 ARG A 227 1 N TRP A 226 O ASP A 264 SHEET 3 A 8 VAL A 199 CYS A 202 1 N CYS A 202 O HIS A 225 SHEET 4 A 8 LEU A 166 ASP A 170 1 N PHE A 169 O SER A 201 SHEET 5 A 8 LYS A 130 ASP A 136 1 N ILE A 133 O LYS A 168 SHEET 6 A 8 TYR A 88 CYS A 90 1 N LEU A 89 O LYS A 130 SHEET 7 A 8 MET A 42 LEU A 45 1 N TRP A 44 O CYS A 90 SHEET 8 A 8 LEU A 294 MET A 296 1 O MET A 296 N LEU A 45 SHEET 1 B 6 TYR A 329 GLY A 334 0 SHEET 2 B 6 PHE A 337 PRO A 343 -1 O VAL A 339 N LEU A 331 SHEET 3 B 6 ALA A 348 ASN A 355 -1 O ALA A 352 N TRP A 340 SHEET 4 B 6 THR A 412 THR A 420 -1 O LEU A 417 N TRP A 349 SHEET 5 B 6 ALA A 381 LEU A 388 -1 N LEU A 387 O LEU A 414 SHEET 6 B 6 ARG A 392 GLU A 398 -1 O TYR A 397 N CYS A 382 SHEET 1 C 2 ARG A 363 ALA A 368 0 SHEET 2 C 2 ARG A 402 ILE A 407 -1 O SER A 405 N TYR A 365 SHEET 1 D 8 TRP B 262 ASP B 264 0 SHEET 2 D 8 HIS B 225 ARG B 227 1 N TRP B 226 O ASP B 264 SHEET 3 D 8 VAL B 199 CYS B 202 1 N CYS B 202 O HIS B 225 SHEET 4 D 8 LEU B 166 ASP B 170 1 N LEU B 167 O SER B 201 SHEET 5 D 8 LYS B 130 ASP B 136 1 N ILE B 133 O LYS B 168 SHEET 6 D 8 TYR B 88 CYS B 90 1 N LEU B 89 O LYS B 130 SHEET 7 D 8 MET B 42 LEU B 45 1 N TRP B 44 O CYS B 90 SHEET 8 D 8 LEU B 294 MET B 296 1 O MET B 296 N LEU B 45 SHEET 1 E 6 TYR B 329 GLY B 334 0 SHEET 2 E 6 PHE B 337 PRO B 343 -1 O VAL B 339 N LEU B 331 SHEET 3 E 6 ALA B 348 ASN B 355 -1 O ALA B 352 N TRP B 340 SHEET 4 E 6 THR B 412 THR B 420 -1 O LEU B 417 N TRP B 349 SHEET 5 E 6 ALA B 381 LEU B 388 -1 N LEU B 387 O LEU B 414 SHEET 6 E 6 ARG B 392 GLU B 398 -1 O ARG B 392 N GLN B 386 SHEET 1 F 2 ARG B 363 ALA B 368 0 SHEET 2 F 2 ARG B 402 ILE B 407 -1 O LEU B 403 N ILE B 367 SSBOND 1 CYS A 52 CYS A 94 1555 1555 2.04 SSBOND 2 CYS A 56 CYS A 63 1555 1555 2.04 SSBOND 3 CYS A 142 CYS A 172 1555 1555 2.04 SSBOND 4 CYS A 202 CYS A 223 1555 1555 2.06 SSBOND 5 CYS A 378 CYS A 382 1555 1555 2.05 SSBOND 6 CYS B 52 CYS B 94 1555 1555 2.04 SSBOND 7 CYS B 56 CYS B 63 1555 1555 2.05 SSBOND 8 CYS B 142 CYS B 172 1555 1555 2.04 SSBOND 9 CYS B 202 CYS B 223 1555 1555 2.06 SSBOND 10 CYS B 378 CYS B 382 1555 1555 2.04 LINK ND2 ASN A 139 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 192 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN A 215 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN B 139 C1 NAG B 639 1555 1555 1.45 LINK ND2 ASN B 192 C1 NAG F 1 1555 1555 1.45 LINK ND2 ASN B 215 C1 NAG G 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK O3 NAG C 1 C1 FUC C 7 1555 1555 1.45 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.44 LINK O2 BMA C 3 C1 XYP C 4 1555 1555 1.45 LINK O3 BMA C 3 C1 MAN C 5 1555 1555 1.45 LINK O6 BMA C 3 C1 MAN C 6 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O3 NAG D 1 C1 FUC D 5 1555 1555 1.46 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.45 LINK O2 BMA D 3 C1 XYP D 4 1555 1555 1.45 LINK O3 NAG E 1 C1 FUC E 2 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 3 1555 1555 1.45 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.44 LINK O2 BMA F 3 C1 XYP F 4 1555 1555 1.44 LINK O3 BMA F 3 C1 MAN F 5 1555 1555 1.45 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.45 LINK O3 NAG G 1 C1 FUC G 4 1555 1555 1.44 LINK O4 NAG G 2 C1 BMA G 3 1555 1555 1.45 CISPEP 1 ASN A 379 PRO A 380 0 -4.34 CISPEP 2 LEU A 388 PRO A 389 0 2.12 CISPEP 3 ASN B 379 PRO B 380 0 -0.44 CISPEP 4 LEU B 388 PRO B 389 0 -0.67 CRYST1 136.813 182.635 47.730 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007309 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005475 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020951 0.00000